Cargando…
Perchlozone Resistance in Clinical Isolates of Mycobacterium tuberculosis
The emergence of drug-resistant tuberculosis forced the development of new drugs and the screening of more effective or less toxic analogues. Mycolic acid biosynthesis is targeted by several antituberculosis drugs, isoniazid being one of the most important in tuberculosis therapy. Recently, perchloz...
Autores principales: | Ushtanit, Anastasia, Mikhailova, Yulia, Krylova, Ludmila, Grigorash, Dmitry, Makarova, Marina, Safonova, Svetlana, Zimenkov, Danila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044601/ https://www.ncbi.nlm.nih.gov/pubmed/36978456 http://dx.doi.org/10.3390/antibiotics12030590 |
Ejemplares similares
-
Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis
por: Ushtanit, Anastasia, et al.
Publicado: (2022) -
Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow
por: Ushtanit, Anastasia, et al.
Publicado: (2021) -
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia
por: Nosova, Elena Y., et al.
Publicado: (2016) -
Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays
por: Zimenkov, Danila V, et al.
Publicado: (2013) -
Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
por: Mokrousov, Igor, et al.
Publicado: (2020)